Suppr超能文献

超重和维生素 D 缺乏在肠易激综合征患者中很常见——一项横断面研究。

Overweight and vitamin D deficiency are common in patients with irritable bowel syndrome - a cross-sectional study.

机构信息

Department of Internal Medicine, Skåne University Hospital, Jan Waldenströms Street 15, floor 5, Malmö, 205 02, Sweden.

Department of Clinical Sciences, Lund University, Malmö, Sweden.

出版信息

BMC Gastroenterol. 2024 Sep 3;24(1):296. doi: 10.1186/s12876-024-03373-x.

Abstract

BACKGROUND

Irritable bowel syndrome (IBS) is a common disease with unknown etiology. Poor dietary intake with nutritional deficiency and overweight have been described to increase the risk of IBS. The aim of the present study was to compare weight and circulating levels of micronutrients in IBS compared with healthy controls.

DESIGN

Cross-sectional study.

METHODS

Patients diagnosed with IBS and healthy volunteers were recruited. Participants had to complete a dietary diary book and the questionnaires Rome IV, IBS-severity scoring system (IBS-SSS), and visual analog scale for IBS (VAS-IBS). Weight and height were measured, and blood samples were drawn. C-reactive protein (CRP), cobalamin, folate, iron, total iron-binding capacity (TIBC), and 25-hydroxy (25-OH) vitamin D were analyzed. Differences were calculated between groups and generalized linear model for regressions was adjusted for false discovery rate (FDR).

RESULTS

IBS patients (n = 260) were elder than controls (n = 50) (44.00 (33.25-56.00) vs. 37.85 (30.18-45.48) years; p = 0.012). After adjustment for age, both weight (β: 5.880; 95% CI: 1.433-10.327; p = 0.010, FDR = 0.020) and body mass index (BMI) (β: 2.02; 95% CI: 0.68-3.36; p = 0.003, FDR = 0.012) were higher in patients. Among IBS participants, 48.1% were overweight/obese compared with 26.0% in controls (p = 0.007). Diarrhea-predominated IBS had highest weight (p < 0.001) and BMI (p = 0.077). CRP and cobalamin were higher in patients than controls (p = 0.010 vs. p = 0.007), whereas folate was highest in controls (p = 0.001). IBS patients had lower intake of vegetables (p = 0.026), dairy products (p = 0.004), and cereals (p = 0.010) compared with controls. Despite 21.5% of IBS patients were taking vitamin D supplements, 23.65% of them had vitamin D levels below 50 nmol/L, compared with 26.0% observed in the control group (p = 0.720). Vitamin D levels were lower in overweight than in normal weight IBS patients (60 (48-73) nmol/L vs. 65 (53-78) nmol/L, p = 0.022). Vitamin D correlated with cobalamin and folate but correlated inversely with TIBC and BMI. IBS patients had a high degree of gastrointestinal and extraintestinal symptoms, which were inversely associated with iron levels. Extraintestinal symptoms were associated with increased BMI.

CONCLUSION

IBS patients were often overweight or obese, with low vitamin D levels. High burden of extraintestinal symptoms were associated with overweight and lower iron levels.

REGISTRATION

ClinicalTrials.gov, NCT05192603 (Date of registration 11/29/2021) and NCT03306381 (Date of registration 09/18/2017), respectively.

摘要

背景

肠易激综合征(IBS)是一种病因不明的常见疾病。不良的饮食摄入和营养缺乏以及超重已被描述为增加 IBS 的风险。本研究的目的是比较 IBS 患者与健康对照组的体重和循环微量营养素水平。

设计

横断面研究。

方法

招募了被诊断为 IBS 的患者和健康志愿者。参与者必须完成饮食日记手册和罗马 IV 问卷、IBS 严重程度评分系统(IBS-SSS)和 IBS 视觉模拟量表(VAS-IBS)。测量体重和身高,并抽取血液样本。分析 C 反应蛋白(CRP)、钴胺素、叶酸、铁、总铁结合能力(TIBC)和 25-羟维生素 D(25-OH 维生素 D)。计算组间差异,并使用广义线性模型进行回归,同时进行虚假发现率(FDR)校正。

结果

IBS 患者(n=260)比对照组(n=50)年龄更大(44.00(33.25-56.00)比 37.85(30.18-45.48)岁;p=0.012)。校正年龄后,体重(β:5.880;95%置信区间:1.433-10.327;p=0.010,FDR=0.020)和 BMI(β:2.02;95%置信区间:0.68-3.36;p=0.003,FDR=0.012)均在患者中更高。在 IBS 参与者中,48.1%超重/肥胖,而对照组为 26.0%(p=0.007)。腹泻为主型 IBS 的体重(p<0.001)和 BMI(p=0.077)最高。与对照组相比,患者的 CRP 和钴胺素更高(p=0.010 与 p=0.007),而对照组的叶酸最高(p=0.001)。与对照组相比,IBS 患者摄入的蔬菜(p=0.026)、乳制品(p=0.004)和谷物(p=0.010)较少。尽管 21.5%的 IBS 患者正在服用维生素 D 补充剂,但他们中有 23.65%的维生素 D 水平低于 50 nmol/L,而对照组为 26.0%(p=0.720)。超重的 IBS 患者的维生素 D 水平低于正常体重的 IBS 患者(60(48-73)nmol/L 比 65(53-78)nmol/L,p=0.022)。维生素 D 与钴胺素和叶酸相关,但与 TIBC 和 BMI 呈负相关。IBS 患者有高度的胃肠道和肠外症状,这些症状与铁水平呈负相关。肠外症状与 BMI 增加有关。

结论

IBS 患者通常超重或肥胖,维生素 D 水平较低。大量的肠外症状与超重和较低的铁水平有关。

注册

ClinicalTrials.gov,NCT05192603(注册日期 2021 年 11 月 29 日)和 NCT03306381(注册日期 2017 年 9 月 18 日)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2352/11370284/041d3da348ec/12876_2024_3373_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验